Price & resources

SUBLOCADE pricing

What to know about paying for SUBLOCADE.

Pay as little as $5 per monthly dose of SUBLOCADE, if eligible.*

There is copay assistance offered through the INSUPPORT® Copay Assistance Program, which may help eligible patients with their out-of-pocket costs for SUBLOCADE. If a patient is eligible for copay assistance, they may pay as little as $5 per monthly dose of SUBLOCADE. For the first two doses of each calendar year, an expanded copay assistance amount of up to the list price of SUBLOCADE is provided. Following the first two doses, the copay for subsequent doses for the remainder of the calendar year may be reduced. The expanded copay assistance of up to the list price resets at the beginning of the calendar year. The program is applicable to medical expenses of the drug, not administration costs. If you have additional questions about copay, download the INSUPPORT® Copay Assistance Brochure.

Check Eligibility

INSUPPORT® Copay Assistance Program may provide information on insurance coverage and copay assistance for SUBLOCADE. Learn more about INSUPPORT Copay Assistance for patients

*The INSUPPORT® Copay Assistance Program is valid ONLY for patients with private insurance who are prescribed SUBLOCADE® (buprenorphine extended-release) for on-label use. Patients with government insurance are not eligible for the Copay Assistance Program, including, but not limited to, Medicare, Medicaid, Medigap, VA, DOD, TriCare, CHAMPVA, or any other federally or state-funded government-assisted program. Other restrictions apply. See here for full Terms & Conditions. Subject to change.

Find a buprenorphine treatment provider

The Substance Abuse and Mental Health Services Agency (SAMHSA) also provides treatment information. Visit the SAMHSA website to find a facility near you that can provide treatment based on patient-specific criteria. Download steps for using SAMHSA's 
Treatment Services Locator
.

For more information on how to find a facility, call INSUPPORT® at 1-844-467-7778.

UNDERSTANDING THE PRICE FOR SUBLOCADE®‡

It can be hard to understand what you have to pay for the medicines that you are prescribed. Depending on insurance coverage, coupon offers, and other savings tools, people may end up paying different out-of-pocket amounts.

The list price* of SUBLOCADE (for both 300 mg and 100 mg dosage forms) is $1741.95 per month. However, most people will not pay this amount.

If you have commercial insurance

You could pay between $1 - $2103 per month, with the average out-of-pocket cost for SUBLOCADE itself being $187.04 or less.

If you have Medicare

You could pay between $3 - $1105 per dose (whether 300 mg or 100 mg) if you are receiving SUBLOCADE once monthly (depending on your specific Medicare benefits), with the average out-of-pocket cost of SUBLOCADE itself being $88.29 or less. If you have Medicare Part B, you may also have a supplemental insurance plan that will pay all or part of your SUBLOCADE costs. If you have Medicare Part C, there is an out-of-pocket maximum and what you will pay for SUBLOCADE depends on your plan's benefit design and the level of other healthcare expenses you have during the year. Please check with your Medicare plan administrator for further details.

If you have Medicaid

You could pay between $0.60 and $1689 per month, (depending on the state plan), with the average out-of-pocket cost of SUBLOCADE itself being $4.90 or less. To find out if you qualify for Medicaid, or to get more information about copayments in your state, please use this link to visit the Medicaid website.

If you do not have insurance coverage

If you do not have medical coverage for SUBLOCADE, you can expect to pay the list price shown above.

Talk to your insurance provider for the most accurate information for you.

*An estimate of the manufacturer's list price for a drug to wholesalers or other direct purchasers, not including discounts or rebates. This price is defined by federal law. This information is accurate as of Jan 1, 2021. The list prices listed may differ significantly from actual prices paid by customers and consumers. In addition, a product's list price is typically not associated with per-dose pricing and does not necessarily reflect price per dosage or price per course of treatment.

Symphony Health, PayerSource®, December 2019 – November 2020. Calculations were based on a survey of pharmacy and medical claim amounts for SUBLOCADE alone, only when paid units for claims were 0.5, 1.0, or 1.5. These calculations were examined across Commercial managed care plans, Medicare managed care plans, and Medicaid managed care plans prior to any discounts or copay card applications and exclude zero dollar claims and data outliers.

Indivior cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims. For additional information, customers should consult with their payors for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record.

Want information?

Find out more about opioid addiction and treating it.

Get Updates

IMPORTANT SAFETY INFORMATION AND INDICATION

What is the most important information I should know about SUBLOCADE?

Because of the serious risk of potential harm or death from self-injecting SUBLOCADE into a vein (intravenously), it is only available through a restricted program called the SUBLOCADE REMS Program.

SUBLOCADE contains an opioid medicine called buprenorphine that can cause serious and life-threatening breathing problems, especially if you take or use certain other medicines or drugs.

Talk to your healthcare provider about naloxone, a medicine available to patients for emergency treatment of an opioid overdose. If naloxone is given, you must call 911 or get emergency medical help right away to treat overdose or accidental use of an opioid.

SUBLOCADE may cause serious and life‐threatening breathing problems. Get emergency help right away if you:

Do not take certain medicines during treatment with SUBLOCADE. Taking other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) while on SUBLOCADE can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.

Death has been reported in those who are not opioid dependent who received buprenorphine sublingually.

Who should not take SUBLOCADE?

Do not use SUBLOCADE if you are allergic to buprenorphine or any ingredient in the prefilled syringe (ATRIGEL® Delivery System, a biodegradable 50:50 poly(DL-lactide-co-glycolide) polymer and a biocompatible solvent, N-methyl-2-pyrrolidone (NMP)).

Before starting SUBLOCADE, tell your healthcare provider about all of your medical conditions, including if you have:

Tell your healthcare provider if you are:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.

What should I avoid while being treated with SUBLOCADE?

What are the possible side effects of SUBLOCADE?

SUBLOCADE can cause serious side effects, including:

These are not all the possible side effects. Call your healthcare provider for medical advice about side effects.

To report pregnancy or side effects associated with taking SUBLOCADE, please call 1-877-782-6966. You are encouraged to report negative side effects of drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication

SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is a prescription medicine used to treat adults with moderate to severe addiction (dependence) to opioid drugs (prescription or illegal) who have received an oral transmucosal (used under the tongue or inside the cheek) buprenorphine-containing medicine at a dose that controls withdrawal symptoms for at least 7 days. SUBLOCADE is part of a complete treatment plan that should include counseling.

For more information about SUBLOCADE, see the full Prescribing Information including BOXED WARNING, and Medication Guide or talk to your healthcare provider. For REMS information visit www.sublocadeREMS.com.